Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells - Wu, Shixing; Liu, Bin; Zhang, Qingyu; Liu, Jie; Zhou, Wei; Wang, Chang; Li, Mingyi; Bao, Shiting; Zhu, Runzhi (PloS one, 2013)
Keywords: Analysis; Anticancer properties; Antineoplastic Agents - pharmacology; Antitumor activity; Apoptosis; BAX protein; Bcl-2 protein; bcl-2-Associated X Protein - genetics; bcl-2-Associated X Protein - metabolism; Bromine compounds; Cell cycle; Cell Proliferation - drug effects; Cytotoxicity; Down-Regulation - drug effects; Drug Screening Assays, Antitumor; Flavonoids; Flavonols - pharmacology; Gene expression; Hep G2 Cells; Hepatocellular carcinoma; Hepatoma; Humans; Kinases; Laboratories; Leukemia; Liver cancer; Medicine; p53 Protein; Prostate cancer; Proto-Oncogene Proteins c-bcl-2 - genetics; Proto-Oncogene Proteins c-bcl-2 - metabolism; Ribonucleic acid; RNA; Signal Transduction; Silence; siRNA; Surgery; Tumor proteins; Tumor Suppressor Protein p53 - physiology; Viability; Wu, Bin; China